Mycoses clinical trials at UC Health
1 research study open to new patients
-
A Study of Experimental Medicine CD101 For Candidemia and/or Invasive Candidiasis (fungal infections in the blood and/or organs)
open to eligible people ages 18 years and up
The purpose of this study is to determine if intravenous CD101 is safe and effective in the treatment of candidemia and/or invasive candidiasis when compared to caspofungin (followed by oral fluconazole).
at UC Davis
Last updated: